FDA Announces New Recommendations for Acceptable Limits of Nitrosamine in Drugs
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
The FDA has released new guidance on acceptable intake limits for certain nitrosamines and how drug manufacturers should test for them.
Harvard researchers warn that drug companies spend billions of dollars advertising medications which are not as effective, and often more expensive, than other options, researchers warn.
All Chantix recall cancer lawsuits are to be consolidated in a southern New York federal court for pretrial proceedings.
The FDA has been caught off-guard by the number of drugs being recalled for nitrosamine contamination and is likely to update a 2020 guidance to better address the problem according…
A panel of federal judges will decide whether to create a Chantix recall lawsuits multidistrict litigation following oral arguments scheduled for December 1.
A motion has been filed to consolidate all Chantix lawsuits before one judge for pretrial proceedings in federal court.
A class action lawsuit claims the presence of potentially cancer-causing chemicals made Chantix an illegal and unadulterated drug which was never approved by the FDA.
A class action lawsuit filed after a recent Chantix recall claims the drug was illegally marketed due to the lack of warnings that it may contain cancer-causing substances.
Nearly 80 lots of Irbesartan and Irbesartan/HCTZ combination tablets are being recalled due to the presence of a potentially cancer-causing chemical.
The first generic version of Chantix has been announced just days after a complete recall of the brand name smoking cessation drug.